monoclonal antibodies

Lpath: The Leader In Lipidomics

Lpath: The Leader In Lipidomics

Seeking Alpha

Biotech Corner: Monoclonal Antibody Companies

Biotech Corner: Monoclonal Antibody Companies

Seeking Alpha

Lpath Begins iSONEP Dosing in Nexus Phase 2 Study

Lpath Begins iSONEP Dosing in Nexus Phase 2 Study

Yahoo

Lilly releases Phase II results for monoclonal antibody ramucirumab

Lilly releases Phase II results for monoclonal antibody ramucirumab

The Fly on the Wall

AVEO Oncology initiates Phase 1 study of AV-203

AVEO Oncology initiates Phase 1 study of AV-203

Yahoo

The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results

The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results

TheStreet.com

SIRO Clinpharm and Peregrine Pharmaceuticals highlight successful collaboration

SIRO Clinpharm and Peregrine Pharmaceuticals highlight successful collaboration

PharmaLive

Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial

Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial

Yahoo

Blockbuster antibodies face a unique set of challenges

Blockbuster antibodies face a unique set of challenges

Fierce Biotech

Ipilimumab Approval Highlights Active Immunotherapy Renaissance

Ipilimumab Approval Highlights Active Immunotherapy Renaissance

Seeking Alpha